Therapeutic Solutions International, Inc.
TSOI
$0.0001
$0.000.00%
OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 85.30K | 91.30K | 97.60K | 98.90K | 83.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 85.30K | 91.30K | 97.60K | 98.90K | 83.70K |
| Cost of Revenue | 29.20K | 31.90K | 35.90K | 36.90K | 72.30K |
| Gross Profit | 56.20K | 59.60K | 61.90K | 62.30K | 11.60K |
| SG&A Expenses | 3.41M | 1.78M | 1.73M | 1.49M | 1.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.68M | 2.18M | 2.33M | 2.09M | 2.47M |
| Operating Income | -3.59M | -2.09M | -2.23M | -1.99M | -2.39M |
| Income Before Tax | -3.74M | -2.31M | -2.41M | -2.22M | -2.88M |
| Income Tax Expenses | 2.30K | 2.30K | 2.30K | 2.30K | 1.60K |
| Earnings from Continuing Operations | -3.74 | -2.31 | -2.41 | -2.22 | -2.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.33M | 307.40K | 234.00K | 54.90K | 65.80K |
| Net Income | -2.41M | -2.00M | -2.18M | -2.17M | -2.82M |
| EBIT | -3.59M | -2.09M | -2.23M | -1.99M | -2.39M |
| EBITDA | -3.28M | -1.78M | -1.92M | -1.67M | -2.11M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 17.09B | 15.47B | 13.93B | 12.67B | 11.56B |
| Average Diluted Shares Outstanding | 17.09B | 15.47B | 13.93B | 12.67B | 11.56B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |